OLBA HEALTHCARE HOLDINGS, Inc. (TYO:2689)
2,116.00
+1.00 (0.05%)
Feb 16, 2026, 1:25 PM JST
OLBA HEALTHCARE HOLDINGS Revenue
OLBA HEALTHCARE HOLDINGS had revenue of 31.62B JPY in the quarter ending December 31, 2025, with 0.12% growth. This brings the company's revenue in the last twelve months to 124.52B, up 2.30% year-over-year. In the fiscal year ending June 30, 2025, OLBA HEALTHCARE HOLDINGS had annual revenue of 122.70B with 3.49% growth.
Revenue (ttm)
124.52B
Revenue Growth
+2.30%
P/S Ratio
0.10
Revenue / Employee
89.39M
Employees
1,393
Market Cap
12.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 122.70B | 4.14B | 3.49% |
| Jun 30, 2024 | 118.56B | 8.09B | 7.32% |
| Jun 30, 2023 | 110.47B | 2.51B | 2.33% |
| Jun 30, 2022 | 107.96B | -5.02B | -4.44% |
| Jun 30, 2021 | 112.98B | 5.08B | 4.71% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.46T |
| Otsuka Holdings | 2.47T |
| Chugai Pharmaceutical | 1.26T |
| HOYA Corporation | 915.21B |
| Satudora Holdings | 100.84B |
| DVx Inc. | 55.33B |
| Japan Medical Dynamic Marketing, INC. | 24.58B |
| SAKURASAKU PLUS,Co.,Ltd. | 18.91B |